These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 17699195

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Shiga toxin-associated hemolytic uremic syndrome: absence of recurrence after renal transplantation.
    Ferraris JR, Ramirez JA, Ruiz S, Caletti MG, Vallejo G, Piantanida JJ, Araujo JL, Sojo ET.
    Pediatr Nephrol; 2002 Oct; 17(10):809-14. PubMed ID: 12376808
    [Abstract] [Full Text] [Related]

  • 4. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.
    Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, Macher MA, Niaudet P, Guest G, Boudailliez B, Bouissou F, Deschenes G, Gie S, Tsimaratos M, Fischbach M, Morin D, Nivet H, Alberti C, Loirat C, French Society of Pediatric Nephrology.
    J Am Soc Nephrol; 2007 Aug; 18(8):2392-400. PubMed ID: 17599974
    [Abstract] [Full Text] [Related]

  • 5. [Hemolytic uremic syndrome].
    Mele C, Noris M.
    G Ital Nefrol; 2007 Aug; 24(1):23-33. PubMed ID: 17342690
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Hemolytic uremic syndrome].
    Rota S, Cravedi P, Remuzzi G, Ruggenenti P.
    G Ital Nefrol; 2005 Aug; 22 Suppl 33():S57-64. PubMed ID: 16419008
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome.
    Richards A, Kathryn Liszewski M, Kavanagh D, Fang CJ, Moulton E, Fremeaux-Bacchi V, Remuzzi G, Noris M, Goodship TH, Atkinson JP.
    Mol Immunol; 2007 Jan; 44(1-3):111-22. PubMed ID: 16882452
    [Abstract] [Full Text] [Related]

  • 12. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome.
    Fremeaux-Bacchi V, Moulton EA, Kavanagh D, Dragon-Durey MA, Blouin J, Caudy A, Arzouk N, Cleper R, Francois M, Guest G, Pourrat J, Seligman R, Fridman WH, Loirat C, Atkinson JP.
    J Am Soc Nephrol; 2006 Jul; 17(7):2017-25. PubMed ID: 16762990
    [Abstract] [Full Text] [Related]

  • 13. Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome.
    Kavanagh D, Kemp EJ, Mayland E, Winney RJ, Duffield JS, Warwick G, Richards A, Ward R, Goodship JA, Goodship TH.
    J Am Soc Nephrol; 2005 Jul; 16(7):2150-5. PubMed ID: 15917334
    [Abstract] [Full Text] [Related]

  • 14. Renal transplantation in patients with hemolytic uremic syndrome: high rate of recurrence and increased incidence of acute rejections.
    Artz MA, Steenbergen EJ, Hoitsma AJ, Monnens LA, Wetzels JF.
    Transplantation; 2003 Sep 15; 76(5):821-6. PubMed ID: 14501861
    [Abstract] [Full Text] [Related]

  • 15. Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome.
    Zimmerhackl LB, Besbas N, Jungraithmayr T, van de Kar N, Karch H, Karpman D, Landau D, Loirat C, Proesmans W, Prüfer F, Rizzoni G, Taylor MC, European Study Group for Haemolytic Uraemic Syndromes and Related Disorders.
    Semin Thromb Hemost; 2006 Mar 15; 32(2):113-20. PubMed ID: 16575686
    [Abstract] [Full Text] [Related]

  • 16. Renal transplantation in 20 children with hemolytic-uremic syndrome.
    Eijgenraam FJ, Donckerwolcke RA, Monnens LA, Proesmans W, Wolff ED, van Damme B.
    Clin Nephrol; 1990 Feb 15; 33(2):87-93. PubMed ID: 2311309
    [Abstract] [Full Text] [Related]

  • 17. Tacrolimus-associated hemolytic uremic syndrome: a case analysis.
    Lin CC, King KL, Chao YW, Yang AH, Chang CF, Yang WC.
    J Nephrol; 2003 Feb 15; 16(4):580-5. PubMed ID: 14696762
    [Abstract] [Full Text] [Related]

  • 18. Graft failure due to hemolytic uremic syndrome recurrence.
    Iaria G, Iorio B, Anselmo A, De Luca L, Tariciotti L, Ielpo B, Muzi F, Lucchesi C, D'Andria D, Orlando G, Del Poeta G, Poggi E, Piazza A, Tisone G.
    Transplant Proc; 2006 May 15; 38(4):1020-1. PubMed ID: 16757250
    [Abstract] [Full Text] [Related]

  • 19. Haemolytic uraemic syndrome caused by factor H mutation: is single kidney transplantation under intensive plasmatherapy an option?
    Hirt-Minkowski P, Schaub S, Mayr M, Schifferli JA, Dickenmann M, Frémeaux-Bacchi V, Steiger J.
    Nephrol Dial Transplant; 2009 Nov 15; 24(11):3548-51. PubMed ID: 19633317
    [Abstract] [Full Text] [Related]

  • 20. [Hemolytic-uremic syndrome following kidney transplantation: prognostic factors].
    Candinas D, Keusch G, Schlumpf R, Burger HR, Gmür J, Largiadèr F.
    Schweiz Med Wochenschr; 1994 Oct 15; 124(41):1789-99. PubMed ID: 7973505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.